secwatch.observer — SEC 8-K summary
======================================

Issuer:     Neuraxis, INC (NRXS)
CIK:        0001933567
Form:       8-K
Filed at:   2023-09-21T23:59:59+00:00
Accession:  0001493152-23-033281
Event type: earnings
Sentiment:  negative
Materiality: 0.70
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Neuraxis Q2 2023 revenue down 5% to $646K; net loss widens to $2.24M
--------------------------------------------------------------------

- Revenue $646K, -5% YoY from $683K; gross margin improved to 89.5% from 88.4%.
- Net loss $2.236M ($1.21/share) vs $1.517M ($0.87/share) in Q2 2022.
- IPO completed, net proceeds ~$6.1M; now trading on NYSE American under NRXS.
- R&D spend surged to $110K from $14K YoY; G&A rose to $1.51M from $1.13M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1933567/000149315223033281/0001493152-23-033281-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1933567/000149315223033281/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-033281

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer